These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11715861)

  • 1. Genetic polymorphism at position-308 in the promoter region of the tumor necrosis factor (TNF): implications of its allelic distribution on susceptibility or resistance to diseases in the Chilean population.
    Cuenca J; Pérez CA; Aguirre AJ; Schiattino I; Aguillón JC
    Biol Res; 2001; 34(3-4):237-41. PubMed ID: 11715861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association of tumor necrosis factor alpha 308 G/A gene promoter polymorphism with the presence of chronic obstructive pulmonary disease: a meta-analysis].
    Hu GP; Peng GY; Hu JX; Ran PX
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Aug; 30(8):588-94. PubMed ID: 17988552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis.
    Mitchell SA; Grove J; Spurkland A; Boberg KM; Fleming KA; Day CP; Schrumpf E; Chapman RW;
    Gut; 2001 Aug; 49(2):288-94. PubMed ID: 11454808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor necrosis factor alpha genetic polymorphism as a risk factor in disease].
    Aguillón JC; Cruzat A; Cuenca J; Cuchacovich M
    Rev Med Chil; 2002 Sep; 130(9):1043-50. PubMed ID: 12434654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor alpha gene G-308A polymorphism, insulin resistance, and fasting plasma glucose in young, older, and diabetic Japanese men.
    Ishii T; Hirose H; Saito I; Nishikai K; Maruyama H; Saruta T
    Metabolism; 2000 Dec; 49(12):1616-8. PubMed ID: 11145126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could single-nucleotide polymorphisms (SNPs) affecting the tumour necrosis factor promoter be considered as part of rheumatoid arthritis evolution?
    Aguillón JC; Cruzat A; Aravena O; Salazar L; Llanos C; Cuchacovich M
    Immunobiology; 2006; 211(1-2):75-84. PubMed ID: 16446172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study.
    Mira JP; Cariou A; Grall F; Delclaux C; Losser MR; Heshmati F; Cheval C; Monchi M; Teboul JL; Riché F; Leleu G; Arbibe L; Mignon A; Delpech M; Dhainaut JF
    JAMA; 1999 Aug; 282(6):561-8. PubMed ID: 10450718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mutagenically separated polymerase chain reaction is a rapid and reliable method for genotyping of the tumour necrosis factor-alpha promoter polymorphism (-308 G/A).
    Schlüter B; Erren M; Schotte H; Junker R; Rust S; Assmann G
    Clin Chim Acta; 2002 Jun; 320(1-2):135-8. PubMed ID: 11983212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-alpha promoter gene.
    Ho SY; Wang YJ; Chen HL; Chen CH; Chang CJ; Wang PJ; Chen HH; Guo HR
    Cancer Causes Control; 2004 Sep; 15(7):657-63. PubMed ID: 15280623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha promoter variant 2 (TNF2) is associated with pre-term delivery, infant mortality, and malaria morbidity in western Kenya: Asembo Bay Cohort Project IX.
    Aidoo M; McElroy PD; Kolczak MS; Terlouw DJ; ter Kuile FO; Nahlen B; Lal AA; Udhayakumar V
    Genet Epidemiol; 2001 Nov; 21(3):201-11. PubMed ID: 11668577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha promoter polymorphism is associated with susceptibility to oral squamous cell carcinoma.
    Liu CJ; Wong YK; Chang KW; Chang HC; Liu HF; Lee YJ
    J Oral Pathol Med; 2005 Nov; 34(10):608-12. PubMed ID: 16202081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumor necrosis factor-alpha promoter correlates with progression of primary biliary cirrhosis.
    Tanaka A; Quaranta S; Mattalia A; Coppel R; Rosina F; Manns M; Gershwin ME
    J Hepatol; 1999 May; 30(5):826-9. PubMed ID: 10365808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong association between the -308 TNF promoter polymorphism and allergic rhinitis in Pakistani patients.
    Minhas K; Micheal S; Ahmed F; Ahmed A
    J Investig Allergol Clin Immunol; 2010; 20(7):563-6. PubMed ID: 21313996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy.
    Shu KH; Lee SH; Cheng CH; Wu MJ; Lian JD
    Kidney Int; 2000 Aug; 58(2):783-9. PubMed ID: 10916103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of genetic variation of tumor necrosis factor-alpha on gestational hypertension.
    Chen YP; Pfab T; Slowinski T; Richter CM; Godes M; Hocher B
    Chin Med J (Engl); 2006 May; 119(9):719-24. PubMed ID: 16701011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosis.
    Jones DE; Watt FE; Grove J; Newton JL; Daly AK; Gregory WL; Day CP; James OF; Bassendine MF
    J Hepatol; 1999 Feb; 30(2):232-6. PubMed ID: 10068101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased frequency of the TNF2 allele of TNF-alpha -308 promoter polymorphism is associated with lacunar infarction.
    Harcos P; Laki J; Kiszel P; Széplaki Z; Szolnoki Z; Kovács M; Melegh B; Széplaki G; Füst G; Blaskó B
    Cytokine; 2006 Jan; 33(2):100-5. PubMed ID: 16473522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha gene polymorphisms and haplotypes in Egyptian children with nephrotic syndrome.
    Youssef DM; El-Shal AS; Hussein S; Salah K; Ahmed AERE
    Cytokine; 2018 Feb; 102():76-82. PubMed ID: 28803697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers.
    Jang WH; Yang YI; Yea SS; Lee YJ; Chun JH; Kim HI; Kim MS; Paik KH
    Cancer Lett; 2001 May; 166(1):41-6. PubMed ID: 11295285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of TNF-α (-238 and -308) promoter polymorphisms with susceptibility of oral squamous cell carcinoma in North Indian population.
    Singh PK; Bogra J; Chandra G; Ahmad MK; Gupta R; Kumar V; Jain A; Ali Mahdi A
    Cancer Biomark; 2015; 15(2):125-31. PubMed ID: 25519014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.